The epidemic of hepatitis C virus (HCV) infection in Europe is continuously evolving and
epidemiological parameters (prevalence, incidence, disease transmission patterns and …

Hepatitis C virus (HCV) genotypes 4, 5 and 6 represent> 20% of all HCV cases worldwide.
HCV‐4 is mainly seen in Egypt, where it represents 90% of all HCV cases. Antischistosomal …

Infection with hepatitis C virus (HCV) genotypes 4–6 (with the previously named genotypes
7–9 included as subtypes of genotype 6) is distributed and studied less widely than …

Hepatitis C (HCV) is the disease that has affected around 200 million people globally. HCV
is a life threatening human pathogen, not only because of its high prevalence and worldwide …

It is well established that hepatitis C develops into cirrhosis of the liver and hepatocellular
carcinoma (HCC) both of which are fatal diseases. The World Health Organization estimates …

To describe the spread of hepatitis C virus (HCV) among HCV/human immunodeficiency
virus (HIV)–coinfected injection drug users (IDUs), the molecular epidemiology of HCV was …

Background The global burden of hepatitis C (HCV) infection is mostly found in Africa, the
Middle East and Asia, where HCV genotypes 4, 5 and 6 are common. The literature on these …

Hepatitis C virus (HCV) genotypes' monitoring allows real-time insight into the dynamic
changes that occur in the global epidemiological picture of HCV infection. Intravenous drug …

Hepatitis C virus (HCV) genotype 4 (HCV-4) infection is considered to be difficult to treat and
has become increasingly prevalent in European countries, including The Netherlands …

Hepatitis C virus (HCV) has been classified into six clades as a result of high genetic
variability. In the Seine-Saint-Denis district of north-east Paris, the prevalence of HCV-4 …